 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 February 1996 | Volume 124 Issue 3 | Pages 283-291
Objective: To examine recent trends in the use of thrombolytic therapy in elderly patients who have had acute myocardial infarction and to determine whether failure to meet time-to-hospital presentation and electrocardiographic criteria might explain age-related differences in the use of thrombolytic therapy.
Design: A national registry of patients who have had acute myocardial infarction.
Setting: 1249 U.S. hospitals.
Patients: 350 755 patients who had an acute myocardial infarction from 1 July 1990 to 30 September 1994.
Measurements: Trends in the proportions of patients who received thrombolytic therapy were examined according to age and sex. The association between age and treatment with a thrombolytic agent was determined by crude and multivariable-adjusted analyses.
Results: Use of a thrombolytic agent was inversely related to patient age: Almost 51% of patients younger than age 55 years received a thrombolytic agent during hospitalization for acute myocardial infarction; this proportion decreased to 43.6% for patients aged 55 to 64 years, 33.0% for those aged 65 to 74 years, 19.0% for those aged 75 to 84 years, and 7.4% for those aged 85 years or older. However, relative increases in the use of thrombolytic therapy over time were greatest for patients in the oldest age groups. Between 1 July 1990 and 30 June 1991, 16.0% of patients aged 75 to 84 years received a thrombolytic agent compared with 21.4% between 1 June 1993 and 30 September 1994 (a 33.8% relative increase in use). Among persons aged 85 years or older, the proportion of treated patients increased from 5.3% to 9.1% over this same period (a 71.7% relative increase in use). Increases in thrombolytic use were most prominent for older women. After adjustment for sex, diagnosis by initial electrocardiogram, electrocardiogram-based infarction description, time from symptom onset to hospital presentation, and period of the acute myocardial infarction, the odds of receiving a thrombolytic agent were significantly reduced for patients in the older age groups compared with the odds for patients younger than age 55 years (for patients aged 75 to 84 years, the adjusted odds ratio was 0.27 [95% CI, 0.26 to 0.28]; for patients aged 85 years or older, the odds ratio was 0.09 [CI, 0.08 to 0.10]).
Conclusions: Although older patients who have had acute myocardial infarction less commonly receive a thrombolytic agent, use of thrombolytic therapy in this population is expanding. However, substantial differences across age groups persist in the likelihood of receiving treatment, even after adjustment for potentially confounding factors. Age-related differences in thrombolytic use may not be completely explained by the degree to which older patients do not meet conventional eligibility criteria for thrombolytic therapy.
*A complete listing of participating registry hospitals is available from ClinTrials, Inc., Lexington, KY 40504.
Author and Article Information
From Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; University of Massachusetts Medical School, Worcester, Massachusetts; ClinTrials Research, Inc., Lexington, Kentucky; the Johns Hopkins Bayview Medical Center, Baltimore, Maryland; and the University of Alabama Medical Center, Birmingham, Alabama.
ARTICLE
Recent Age-Related Trends in the Use of Thrombolytic Therapy in Patients Who Have Had Acute Myocardial Infarction
*For the Participants in the National Registry of Myocardial Infarction
Acknowledgments: The authors thank Jack Nyberg for technical assistance with the analyses and Kelley Baron for manuscript preparation.
Grant Support: The National Registry of Myocardial Infarction is supported by Genentech, Inc., South San Francisco, California. Dr. Gurwitz is the recipient of a clinical investigator award (K08 AG00510) from the National Institute on Aging, Bethesda, Maryland.
Requests for Reprints: Jerry H. Gurwitz, MD, Program for the Analysis of Clinical Strategies, Brigham and Women's Hospital, 221 Longwood Avenue, Suite 341, Boston, MA 02115.
Current Author Addresses: Dr. Gurwitz: Program for the Analysis of Clinical Strategies, Brigham and Women's Hospital, 221 Longwood Avenue, Suite 341, Boston, MA 02115.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  H. D. White and J. T. Willerson We Must Use the Knowledge That We Have to Treat Patients With Acute Coronary Syndromes Circulation, February 17, 2004; 109(6): 698 - 700. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sheikh and C. Bullock Sex differences in carotid endarterectomy utilization and 30-day postoperative mortality Neurology, February 11, 2003; 60(3): 471 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Mehta, C. K. Montoye, M. Gallogly, P. Baker, A. Blount, J. Faul, C. Roychoudhury, S. Borzak, S. Fox, M. Franklin, et al. Improving Quality of Care for Acute Myocardial Infarction: The Guidelines Applied in Practice (GAP) Initiative JAMA, March 13, 2002; 287(10): 1269 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Soumerai, T. J. McLaughlin, D. Ross-Degnan, C. L. Christiansen, and J. H. Gurwitz Effectiveness of Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly: Cause for Concern in the Old-Old Arch Intern Med, March 11, 2002; 162(5): 561 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Abete, N. Ferrara, F. Cacciatore, E. Sagnelli, M. Manzi, V. Carnovale, C. Calabrese, D. de Santis, G. Testa, G. Longobardi, et al. High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1357 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Y. Lee, K. P. Alexander, B. G. Hammill, S. K. Pasquali, and E. D. Peterson Representation of Elderly Persons and Women in Published Randomized Trials of Acute Coronary Syndromes JAMA, August 8, 2001; 286(6): 708 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Reed, S. C. Cramer, D. K. Blough, K. Meyer, J. G. Jarvik, and D. Z. Wang Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals Editorial Comment Stroke, August 1, 2001; 32(8): 1832 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Boucher, N. Racine, T. H. Thanh, E. Rahme, J. Brophy, J. LeLorier, and P. Theroux Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction Can. Med. Assoc. J., May 1, 2001; 164(9): 1285 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Berger, M. J. Radford, Y. Wang, and H. M. Krumholz Thrombolytic therapy in older patients J. Am. Coll. Cardiol., August 1, 2000; 36(2): 366 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Abete, C. Calabrese, N. Ferrara, A. Cioppa, P. Pisanelli, F. Cacciatore, G. Longobardi, C. Napoli, and F. Rengo Exercise training restores ischemic preconditioning in the aging heart J. Am. Coll. Cardiol., August 1, 2000; 36(2): 643 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Canto, J. J. Allison, C. I. Kiefe, C. Fincher, R. Farmer, P. Sekar, S. Person, and N. W. Weissman Relation of Race and Sex to the Use of Reperfusion Therapy in Medicare Beneficiaries with Acute Myocardial Infarction N. Engl. J. Med., April 13, 2000; 342(15): 1094 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vaccarino, L. Parsons, N. R. Every, H. V. Barron, H. M. Krumholz, and The National Registry of Myocardial Infarction 2 P Sex-Based Differences in Early Mortality after Myocardial Infarction N. Engl. J. Med., July 22, 1999; 341(4): 217 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gottlieb, V. Boyko, D. Harpaz, H. Hod, M. Cohen, L. Mandelzweig, Z. Khoury, S. Stern, S. Behar, and for the Israeli Thrombolytic Survey Group Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction J. Am. Coll. Cardiol., July 1, 1999; 34(1): 70 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Brass, H. M. Krumholz, J. D. Scinto, D. Mathur, and M. Radford Warfarin Use Following Ischemic Stroke Among Medicare Patients With Atrial Fibrillation Arch Intern Med, October 26, 1998; 158(19): 2093 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vaccarino, R. I. Horwitz, T. P. Meehan, M. K. Petrillo, M. J. Radford, and H. M. Krumholz Sex Differences in Mortality After Myocardial Infarction: Evidence for a Sex-Age Interaction Arch Intern Med, October 12, 1998; 158(18): 2054 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. V. Barron, A. D. Michaels, C. Maynard, N. R. Every, and for the National Registry of Myocardial Infarction Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2 J. Am. Coll. Cardiol., August 1, 1998; 32(2): 360 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Giugliano, C. A. Camargo Jr, D. M. Lloyd-Jones, J. D. Zagrodsky, J. D. Alexis, K. A. Eagle, V. Fuster, and C. J. O'Donnell Elderly Patients Receive Less Aggressive Medical and Invasive Management of Unstable Angina: Potential Impact of Practice Guidelines Arch Intern Med, May 25, 1998; 158(10): 1113 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Baigent, R. Collins, P. Appleby, S. Parish, P. Sleight, and R. Peto ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither BMJ, May 2, 1998; 316(7141): 1337 - 1343. [Abstract] [Full Text]
|
|
|
|
|
|
L. M. Brass, H. M. Krumholz, J. M. Scinto, and M. Radford Warfarin Use Among Patients With Atrial Fibrillation Stroke, December 1, 1997; 28(12): 2382 - 2389. [Abstract] [Full Text]
|
|
|
|
 |
|
 The Elderly and Thrombolytic Drugs . . Journal Watch Cardiology, March 1, 1996; 1996(301): 1 - 1. [Full Text]
|
|
Article
